NEKTAR THERAPEUTICS Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 15.24 | 29,500 | 449,580 | 0 | |
Dec 31 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 15.34 | 29,500 | 452,530 | 260,623 | 290.1 K to 260.6 K (-10.17 %) |
Dec 31 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 15.24 | 29,500 | 449,580 | 290,123 | 260.6 K to 290.1 K (+11.32 %) |
Dec 24 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 11.38 | 5,000 | 56,900 | 0 | |
Dec 24 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 15.56 | 5,000 | 77,800 | 2,999 | 8 K to 3 K (-62.51 %) |
Dec 24 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 11.38 | 5,000 | 56,900 | 7,999 | 3 K to 8 K (+166.72 %) |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 16.31 | 225,000 | 3,669,750 | 225,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 16.31 | 225,000 | 3,669,750 | 225,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 4.65 | 30,000 | 139,500 | 0 | |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 4.65 | 90,000 | 418,500 | 30,000 | |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 17.00 | 30,000 | 510,000 | 4,251 | 34.3 K to 4.3 K (-87.59 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 4.65 | 30,000 | 139,500 | 34,251 | 4.3 K to 34.3 K (+705.72 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 17.02 | 90,000 | 1,531,800 | 4,251 | 94.3 K to 4.3 K (-95.49 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 4.65 | 90,000 | 418,500 | 94,251 | 4.3 K to 94.3 K (+2,117.15 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 209,056 | 1,459,211 | 350,000 | |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 140,944 | 983,789 | 559,056 | |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.00 | 209,056 | 3,553,952 | 10,000 | 219.1 K to 10 K (-95.43 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 209,056 | 1,459,211 | 219,056 | 10 K to 219.1 K (+2,090.56 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.02 | 140,944 | 2,398,867 | 10,000 | 150.9 K to 10 K (-93.38 %) |
Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 140,944 | 983,789 | 150,944 | 10 K to 150.9 K (+1,409.44 %) |